OUR MISSION
Mine and cultivate existing medical archives using computational techniques seeking patterns that can help doctors with disease diagnosis, prognosis, and treatment. Team with technology firms and Health care organizations to access medical data to provide timely, doctor assisted solutions utilizing technologies such as portable devices, cloud computing, and deep learning. To create and predict Early Warning Systems for preventing fatal diseases and ailments.
OUR WORKS
OUR PURPOSE
At the heart of Artelus lies a vision that is both profound and deeply humane. It's a vision that extends beyond the realms of technology and innovation, reaching into the very essence of human vulnerability and resilience. Artelus, an embodiment of hope and compassion, was born out of a desire to protect the most precious gift of sight. Imagine the world slowly fading to darkness, the vibrant colors of life diminishing to shadows—a reality faced by millions of diabetics at risk of losing their vision to the insidious threat of diabetic retinopathy. This is where Artelus steps in, not just as a company, but as a beacon of light in that encroaching darkness. With each eye saved, Artelus isn't just preventing a medical condition; it's preserving the individual stories, the unspoken dreams, and the silent prayers of those who fear a life without sight.
Evidence and recognition
Review the sources behind Artelus product and performance claims. Product results can vary by device, dataset, population, and clinical workflow; DRISTi and OCT AI are intended to support qualified healthcare professionals.
Artelus identifies DRISTi as CE Class I (MDD), with CE Class II B (MDR) under review. The Products page explains the manufacturer's declaration of conformity; request the current certificate and regulatory documentation directly from Artelus.
View certification informationA 96% sensitivity result is reported in Artelus's interview coverage about validation with the Dubai Health Authority. This is a reported historical result, not a universal accuracy guarantee or a substitute for current validation evidence.
Read the validation referenceExplore independent coverage of Artelus's diabetic retinopathy screening work, including reporting on the Dubai Diabetes Hospital results and the company's healthcare mission.
A SHORT VIDEO
Artelus's portable fundus camera, combined with its advanced AI technology, offers a revolutionary approach to diagnosing Diabetic Retinopathy. With its automatic 3D tracking, focusing, and image capture capabilities, the device simplifies the process to a mere two-click operation. The integrated AI has a reported 96% sensitivity in a Dubai Health Authority validation; this historical result is not a universal accuracy guarantee. The system analyzes captured images and supports pathology segmentation and diabetic eye disease grading within seconds.
OUR CLIENTS
1665/A, Hansa Complex, 14th Main Rd, Sector 7, HSR Layout, 560102
Plot-A1-4 Street Number 23, GP Block, Sector V, Bidhannagar, 700091
502 McKnight Dr. ste 100b, Knightdale, 27545
The foundational ethos of Artelus is encapsulated in its forward-thinking vision: Leveraging state-of-the-art Deep Learning architectures to democratize healthcare for the "Forgotten Billions". At Artelus.ai, we are dedicated to advancing eye care through innovative technology and comprehensive solutions, making high-quality diagnostics accessible to all. Join us in revolutionizing healthcare and improving the lives of millions around the world.